Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04583176
Other study ID # 2020_0046
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 16, 2020
Est. completion date July 13, 2021

Study information

Verified date January 2022
Source Hopital Foch
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Objective measurement of physical activity has several advantages compared to declarative measures: exemption from memory bias and desirability bias, more precise evaluation, taken into account activities of low intensity, measurement of physical activity and sedentariness profiles (number and duration of periods of activity, number of breaks in sedentary lifestyles). The aim of this study is to assess the early postoperative mobility of patients who have undergone pulmonary excision by thoracoscopy or robot surgery using ActiGraph GT3X accelerometer. This assessment will serve as a reference element for further studies.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date July 13, 2021
Est. primary completion date July 13, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age = 18 years - Having to undergo pulmonary excision by thoracoscopy or robotic surgery - Accepting to wear a belt fitted with an ActiGraph GT3X accelerometer for a maximum of 5 days post surgery - Affiliated to a Health Insurance plan - Having given an oral non-opposition Exclusion Criteria: - Pregnant or breastfeeding woman - Patient unable to move independently (paraplegic, etc.) - Patient deprived of liberty or under guardianship.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Hôpital Foch Suresnes

Sponsors (1)

Lead Sponsor Collaborator
Hopital Foch

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measurement of postoperative mobility during the first postoperative days Number of steps Day 5
Secondary Volume of physical activity assessed by accelerometry during the first postoperative days Total activity counts per day Day 5
Secondary Overall intensity of physical activity assessed by accelerometry during the first postoperative days Steps and counts per hour and per minute Day 5
Secondary Duration and intensity of physical activity assessed by accelerometry during the first postoperative days Time in physical activity of different intensities Day 5
Secondary Sedentary time assessed by accelerometry during the first postoperative days Total sedentary time Day 5
Secondary Best natural effort assessed by accelerometry during the first postoperative days Peak cadence Day 5
Secondary Patterns of physical activity assessed by accelerometry during the first postoperative days Number and mean duration of bouts of physical activity Day 5
Secondary Patterns of sedentary behavior assessed by accelerometry during the first postoperative days Number and mean duration of bouts of sedentary behavior Day 5
Secondary Physiotherapists' evaluation during the first post-operative days Daily activity assessment after thoracic surgery Questionnaire Day 5
Secondary Postoperative analgesia Daily activity assessment after thoracic surgery Questionnaire Day 5
Secondary Assessement of patient acceptability for wearing the ActiGraph GT3X Digital assessment scale Day 5
Secondary Postoperative complications Morbidity and Mortality after Thoracic Surgery Classification Day 5
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03572335 - Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV)
Recruiting NCT06088485 - The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis
Terminated NCT03309358 - A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis Phase 1
Active, not recruiting NCT02504697 - DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer
Completed NCT01443845 - Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS) Phase 4
Terminated NCT00524095 - Bronchiectasis in Chronic Obstructive Pulmonary Disease (COPD) Patients: Role of Prophylaxis Phase 2
Completed NCT00210249 - Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment
Completed NCT00023114 - p450 Mediated Lung Toxicity N/A
Recruiting NCT06056882 - Simultaneous CLE Guided Crybiopsy in Patients With Pulmonary Nodules
Completed NCT03994848 - Incentive Spirometry Prehabilitation Study N/A
Completed NCT00366509 - Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
Withdrawn NCT05100160 - Gabapentin for the Reduction of Opiate Use Following Pulmonary Resection (GROUP Trial) Phase 3
Completed NCT03229473 - Fall Risk Assessment in COPD
Recruiting NCT04767074 - A Non-pharmacological Cough Control Therapy N/A
Not yet recruiting NCT03899298 - Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions Phase 1
Completed NCT04996693 - On Dose Efficiency of Modern CT-scanners in Chest Scans N/A
Recruiting NCT04996173 - Cryospray Therapy Versus Standard of Care for Benign Airway Stenosis (CryoStasis) N/A
Completed NCT04601545 - The Virtual Reality Therapy as a Pulmonary Rehabilitation Supporting Method N/A
Recruiting NCT03937583 - Screening for Cancer in Patients With Unprovoked VTE Phase 4
Recruiting NCT02862418 - Imaging of Lungs With a New Type of Magnetic Resonance Imaging (MRI) Called UTE (Ultrashort Echo Time)